| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/29/2008 | CA2477538C Chimeric pancreas |
| 01/29/2008 | CA2417455C Novel cyclooxygenase variants and methods of use |
| 01/29/2008 | CA2267651C Method of stimulating growth of melanocyte precursor cells with stem cell factor polypeptide |
| 01/29/2008 | CA2156736C Competitive immunoassay utilizing binding protein in a multiclonal antibody format |
| 01/28/2008 | CA2595306A1 Recombinant antibodies to sclerotinia antigens |
| 01/25/2008 | CA2553402A1 Compositions for inhibiting sema7a and vla-1 interaction and methods of using the same |
| 01/24/2008 | WO2008011609A2 Compositions and methods for vaccinating against hsv-2 |
| 01/24/2008 | WO2008011571A1 Polypeptides with reduced susceptibility to oxidation and methods of making |
| 01/24/2008 | WO2008011348A2 Humanized antibody against amyloid beta |
| 01/24/2008 | WO2008011107A2 Antagonists of protease activated receptor-1 (par1) |
| 01/24/2008 | WO2008010556A1 Remedy for renal disease |
| 01/24/2008 | WO2008010101A2 Antagonist antibody against epha2 for the treatment of cancer |
| 01/24/2008 | WO2008009960A2 Anti-testosterone antibodies |
| 01/24/2008 | WO2008009545A1 Anti-nkg2a antibodies and uses thereof |
| 01/24/2008 | WO2008009179A1 A novel human gene-loc344967 related with nasopharyngeal carcinoma and the protein it encodes |
| 01/24/2008 | WO2007143121A3 Purification of a bivalently active antibody using a non-chromatographic method |
| 01/24/2008 | WO2007139972A3 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 01/24/2008 | WO2007137984A3 Modified humanised anti-interleukin-18 antibodies |
| 01/24/2008 | WO2007137760A3 Dimeric molecular complexes |
| 01/24/2008 | WO2007128553A3 Mig12 |
| 01/24/2008 | WO2007100684A3 Extracellular matrix/metastasis modifer genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor |
| 01/24/2008 | WO2007067856A3 A method for the inactivation and removal of dengue virus from biological samples |
| 01/24/2008 | WO2004016225A8 Compositions and methods for the diagnosis and treatment of tumor |
| 01/24/2008 | US20080021202 For use in diagnosis and therapy of disease; screening for antagonists and agonists of Apop proteins |
| 01/24/2008 | US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/24/2008 | US20080021200 Processes for preparing a polypeptide |
| 01/24/2008 | US20080020969 36 Human Secreted Proteins |
| 01/24/2008 | US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080020462 Atm kinase compositions and methods |
| 01/24/2008 | US20080020457 Neoplasm specific antibodies and uses thereof |
| 01/24/2008 | US20080020432 using branching enzyme from a bacterium of the genus Neisseria; for use in pharmaceutical/cosmetic industries |
| 01/24/2008 | US20080020429 using branching enzyme from a bacterium of the genus Neisseria; for use in pharmaceutical/cosmetic industries |
| 01/24/2008 | US20080020427 using branching enzyme from a bacterium of the genus Neisseria; for use in pharmaceutical/cosmetic industries |
| 01/24/2008 | US20080020410 Assays for detection of bacillus anthracis |
| 01/24/2008 | US20080020408 Anti-Ube4a/Ufd2b Polyclonal Antibody and Its Use Thereof as Diagnostic and Prognostic Marker of 11Q23 Region Alterations |
| 01/24/2008 | US20080020406 Antibodies to a human Kchannel and therapeutic applications thereof |
| 01/24/2008 | US20080020404 Search for cancer markers by a novel screening method |
| 01/24/2008 | US20080020403 Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof |
| 01/24/2008 | US20080020393 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease |
| 01/24/2008 | US20080020375 Method Of Adjudicating On Prostate Cancer |
| 01/24/2008 | US20080020373 Composition for Detecting the Response of Rectal Adenocarcinomas to Radiochemotherapy |
| 01/24/2008 | US20080020372 Methods for Detecting and Treating Cancer |
| 01/24/2008 | US20080020371 Reverse Genetics System |
| 01/24/2008 | US20080020122 FATTY ACID DESATURASES FROM Tetraselmis suecica |
| 01/24/2008 | US20080020011 Therapeutic implant |
| 01/24/2008 | US20080019994 Immunization Against Chlamydia Infection |
| 01/24/2008 | US20080019990 Therapeutic binding agents against MUC-1 antigen and methods for their use |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019984 Blood-brain barrier targeting antibodies |
| 01/24/2008 | US20080019982 Administration of an activated form of ultra-low doses of antibodies to an antigen, obtained using homeopathic techniques; drug dependence/drug withdrawal; side effect reduction |
| 01/24/2008 | US20080019979 HERV-K Antigens, Antibodies, and Methods |
| 01/24/2008 | US20080019977 administering an integrin or integrin subunit antagonist, leukocyte adhesion-inducing cytokine antagonist or growth factor antagonist, a selectin antagonist or adhesion molecule antagonist |
| 01/24/2008 | US20080019976 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 01/24/2008 | US20080019974 Immunoglobulins; cell line |
| 01/24/2008 | US20080019973 Methods for Treating Ocular Inflammation by Neutralizing Cxcl10 Activity |
| 01/24/2008 | US20080019972 Method for Amplifying Therapeutic Vaccine Activity |
| 01/24/2008 | US20080019967 Inflammatory mediator antagonists |
| 01/24/2008 | US20080019966 monoclonal antibodies, hybridomas; immunoglobulins, fab fragments |
| 01/24/2008 | US20080019965 Individualized anti-cancer antibodies |
| 01/24/2008 | US20080019963 Antibodies, polypeptides and uses thereof |
| 01/24/2008 | US20080019962 Endotheliase-2 ligands |
| 01/24/2008 | US20080019958 Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (mgat3), and uses thereof |
| 01/24/2008 | US20080019914 Pesticidally Active Proteins and Polynucleotides Obtainable from Paenibacillus Species |
| 01/24/2008 | US20080019912 Glycoprotein 5 (GP5) and M protein of PRRSV linked by a disulfide bond gives rise to protective antigenic determinant (PAD polypeptide) that is used provide protection PRRSV; immunizing pigs |
| 01/24/2008 | US20080019905 Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection |
| 01/24/2008 | CA2658484A1 Compositions and methods for vaccinating against hsv-2 |
| 01/24/2008 | CA2658286A1 Human glp-1 mimetibodies, compositions, methods and uses |
| 01/24/2008 | CA2658276A1 Antagonist antibody for the treatment of cancer |
| 01/24/2008 | CA2658265A1 Amigo-2 inhibitors for treating, diagnosing or detecting cancer |
| 01/24/2008 | CA2657935A1 Antagonists of protease activated receptor-1 (par1) |
| 01/24/2008 | CA2657934A1 Wsx-1/p28 as a target for anti-inflammatory responses |
| 01/24/2008 | CA2657681A1 Humanized antibodies against beta amyloid protein |
| 01/24/2008 | CA2655623A1 Anti-nkg2a antibodies and uses thereof |
| 01/23/2008 | EP1881327A2 Diagnosis and treatment of malignant neoplasms |
| 01/23/2008 | EP1881070A2 Human cytokine as ligand of the zalpha receptor and uses thereof |
| 01/23/2008 | EP1881065A1 DINO polypetide |
| 01/23/2008 | EP1881064A2 HCV-Anti-core monoclonal antibodies |
| 01/23/2008 | EP1881008A1 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 01/23/2008 | EP1881007A1 LLR-J24 related proteins |
| 01/23/2008 | EP1881004A1 Novel collectin |
| 01/23/2008 | EP1880219A2 Gpr18 as a biomaker for th1 mediated immune response |
| 01/23/2008 | EP1880215A2 Compositions and methods for detection of sirolimus |
| 01/23/2008 | EP1880209A2 Receptor in dendritic cells |
| 01/23/2008 | EP1880005A2 Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions |
| 01/23/2008 | EP1879923A2 Cathepsin s antibody |
| 01/23/2008 | EP1879922A2 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 01/23/2008 | EP1879921A2 Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| 01/23/2008 | EP1879920A2 Fcrn antibodies and uses thereof |
| 01/23/2008 | EP1879919A2 Polypeptide, vaccine and use thereof |
| 01/23/2008 | EP1879916A1 Acute leukemia and lymphoblastic lymphoma-specific cd43 epitope and use thereof |
| 01/23/2008 | EP1879908A1 Immunoglobulin fraction and process therefor |
| 01/23/2008 | EP1879616A2 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 01/23/2008 | EP1879588A2 Combination therapy |
| 01/23/2008 | EP1446478B1 Dimerized growth factor and materials and methods for producing it |
| 01/23/2008 | EP1436316B1 Subcellular targeting of therapeutic proteins |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1240332B1 Streptococcus pyogenes virulence genes and proteins and their use |
| 01/23/2008 | EP1220925B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1210372B1 Human monoclonal antibodies to her2/neu |